Adheris Health (AHE) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
3 Jul, 2026Opening remarks and agenda
Chair welcomed attendees, acknowledged traditional custodians, and confirmed the meeting was virtual-only with all directors online.
Meeting commenced virtually at 10:00 am AEDT, accessible online for all participants.
Confirmed quorum, declared meeting open, and outlined voting and question procedures using Computershare and Zoom.
Specific resolutions to be voted on
Approval of amended Long Term Incentive Plan (LTIP) and issue of up to 31,848,905 securities under the LTIP.
Approval to issue 30,000,000 FY26 employee incentive options to CEO John Ciccio under the LTIP.
Re-election of Mr. Sam Sample and Ms. Jane Citizen as Directors.
Shareholder proposals and voting process
Shareholders could vote 'For', 'Against', or 'Abstain' on each resolution using the online platform.
Latest events from Adheris Health
- Revenue fell 44.6% year-over-year, but cashflow break-even and strong pipeline achieved.AHE
Q4 2026 - Cost discipline, digital innovation, and commercial focus drive growth and profitability.AHE
Investor presentation - Revenue and profit fell, but cost cuts and digital growth support a Q4 cashflow break-even target.AHE
Q3 2026 - Revenue fell 36% year-over-year as US operations struggled, with ANZ business divested post-period.AHE
H2 2025 - Net profit rose to $7.35M on ANZ sale gains, despite revenue drop; focus shifts to US digital growth.AHE
H1 2026 - Revenue down 45.8% year-over-year; cost cuts and new tech platform target recovery.AHE
Q2 2026 - Inaugural profit and 24.6% revenue growth drive a bold 5-year expansion plan.AHE
H2 2024 - Revenue fell 24% but margin gains and cost-saving transformation support future growth.AHE
H1 2025 - Revenue and profit fell 49%+, but FY25 guidance and liquidity are supported by new capital.AHE
Q3 2025